6630-26-8 Usage
Uses
Used in Organic Synthesis:
1,6-Bis(morpholino)-2,4-hexadiyne is used as a building block in organic synthesis for the creation of various biologically active compounds. Its unique structure and reactivity make it a valuable component in the development of new organic molecules.
Used in Pharmaceutical Research:
In pharmaceutical research, 1,6-Bis(morpholino)-2,4-hexadiyne is utilized as a key intermediate for the synthesis of pharmaceuticals. Its properties allow for the exploration of new drug candidates with potential therapeutic benefits.
Used in the Development of New Materials:
1,6-Bis(morpholino)-2,4-hexadiyne is studied for its potential use in the development of new materials, leveraging its chemical properties to contribute to advancements in material science.
Used in the Creation of Bioconjugates:
1,6-Bis(morpholino)-2,4-hexadiyne has also been investigated for its application in the formation of bioconjugates, which can be employed in various biological and medical applications, such as drug delivery and molecular imaging.
Check Digit Verification of cas no
The CAS Registry Mumber 6630-26-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,6,3 and 0 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 6630-26:
(6*6)+(5*6)+(4*3)+(3*0)+(2*2)+(1*6)=88
88 % 10 = 8
So 6630-26-8 is a valid CAS Registry Number.
InChI:InChI=1/C14H20N2O2/c1(3-5-15-7-11-17-12-8-15)2-4-6-16-9-13-18-14-10-16/h5-14H2
6630-26-8Relevant academic research and scientific papers
NOVEL COMPOUNDS, THEIR PREPARATION AND USE
-
Page/Page column 142, (2008/06/13)
Novel compounds of the general formula (I), the use of these compounds as phar- maceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these compounds and compositions. The present compounds are activators of PPARδ and should be useful for treating conditions mediated by the same.
